Prostatic therapeutic efficacy of leniluts®, a novel formulation with multi-active principles

HIGHLIGHTS

• who: Erik Tedesco and collaborators from the Corso Stati Uniti, Padova, PD, Italy Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, PD, Italy have published the paper: Prostatic Therapeutic Efficacy of LENILUTSu00ae, a Novel Formulation with Multi-Active Principles, in the Journal: Pharmaceutics 2022, 1866 of /2022/
• what: The authors compared using an in vitro approach the safety a 5u03b1R inhibitor Dutasteride.

SUMMARY

Lower Urinary Tract Symptoms (LUTS) are a group of urinary symptoms triggered by an obstruction, abnormality, infection or irritation of the lower urinary tract (i.e . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.